Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Surgery Partners (SGRY) Shares Outstanding (Diluted Average) (2016 - 2025)

Surgery Partners' Shares Outstanding (Diluted Average) history spans 12 years, with the latest figure at $127.2 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Diluted Average) rose 0.86% year-over-year to $127.2 million; the TTM value through Dec 2025 reached $127.2 million, up 0.86%, while the annual FY2025 figure was $127.2 million, 0.86% up from the prior year.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $127.2 million at Surgery Partners, roughly flat from $126.9 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $127.4 million in Q2 2023 and bottomed at $54.8 million in Q1 2021.
  • The 5-year median for Shares Outstanding (Diluted Average) is $125.6 million (2023), against an average of $107.0 million.
  • The largest annual shift saw Shares Outstanding (Diluted Average) skyrocketed 64.81% in 2022 before it dropped 1.03% in 2024.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $72.4 million in 2021, then increased by 26.96% to $92.0 million in 2022, then soared by 36.61% to $125.6 million in 2023, then rose by 0.41% to $126.1 million in 2024, then increased by 0.86% to $127.2 million in 2025.
  • Per Business Quant, the three most recent readings for SGRY's Shares Outstanding (Diluted Average) are $127.2 million (Q4 2025), $126.9 million (Q3 2025), and $127.0 million (Q2 2025).